These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 2004887)
1. B lymphocyte changes induced by peri-operative blood transfusions and surgery in patients with colorectal cancer. Ziv Y; Shohat B; Gelerenter I; Wolloch Y Isr J Med Sci; 1991 Feb; 27(2):75-8. PubMed ID: 2004887 [TBL] [Abstract][Full Text] [Related]
2. The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma. Ziv Y; Shohat B; Gelerenter I; Wolloch Y Panminerva Med; 1992; 34(1):4-12. PubMed ID: 1589258 [TBL] [Abstract][Full Text] [Related]
4. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245 [TBL] [Abstract][Full Text] [Related]
5. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596 [TBL] [Abstract][Full Text] [Related]
7. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study. Christodoulakis M; Tsiftsis DD; Ann Surg Oncol; 2005 Sep; 12(9):718-25. PubMed ID: 16052276 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
9. The effect of preoperative blood transfusion on morbidity and survival in colorectal malignancy. Nursal TZ; Hamaloğlu E Turk J Gastroenterol; 2006 Dec; 17(4):283-7. PubMed ID: 17205407 [TBL] [Abstract][Full Text] [Related]
10. Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711 [TBL] [Abstract][Full Text] [Related]
11. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879 [TBL] [Abstract][Full Text] [Related]
12. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
14. [Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery]. Heiss MM; Mempel W; Delanoff C; Mempel M; Jauch KW; Schildberg FW Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():25-9. PubMed ID: 8374284 [TBL] [Abstract][Full Text] [Related]
15. A descriptive study of immune status in patients undergoing colorectal surgery: lymphocyte phenotypes. Tax AW; Orsi AJ; Lafferty M; Barsevick A; Luborsky L; Prystowsky M; Nahass D; Lowery B; McCorkle R Oncol Nurs Forum; 1994 Oct; 21(9):1539-44. PubMed ID: 7816679 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
17. [Blood transfusion worsens the prognosis in colorectal cancer. Preliminary study in a series of 717 cases]. Pellicer Franco EM; García Olmo D; Parrilla Paricio P; Morales Cuenca G; Prieto A Rev Esp Enferm Dig; 1990 Mar; 77(3):189-92. PubMed ID: 2378757 [TBL] [Abstract][Full Text] [Related]
18. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847 [TBL] [Abstract][Full Text] [Related]
19. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Nakafusa Y; Tanaka T; Tanaka M; Kitajima Y; Sato S; Miyazaki K Dis Colon Rectum; 2004 Dec; 47(12):2055-63. PubMed ID: 15657654 [TBL] [Abstract][Full Text] [Related]
20. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C. Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]